Pregnancy and Developmental Outcomes After Transfer of Reportedly Aneuploid or Mosaic Embryos
Transfer of Aneuploid or Mosaic Embryos Following Preimplantation Genetic Testing
Stanford University
300 participants
Apr 11, 2019
INTERVENTIONAL
Conditions
Summary
To determine how often embryos reported to be abnormal by preimplantation genetic testing result in liveborn infants. To evaluate whether the pregnancies that result from these embryos are higher risk for complications and whether the resulting babies have higher risk for health or developmental issues in the first five years after birth.
Eligibility
Inclusion Criteria4
- Available aneuploid or mosaic embryos
- No other acceptable embryos available
- Willing to travel to Stanford for treatment
- English language fluency
Exclusion Criteria3
- Use of international donor eggs or sperm not tested according to FDA guidelines.
- Living outside the United States
- Embryos with Triploidy are not eligible for transfer in this protocol
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Other than choice of embryo for transfer, all other medical interventions will be standard of care protocols
Standard of Care Protocol
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04109846